Skip to main content

Breadcrumb

  1. Home

Spatial Analysis of Genomic Signatures on Colorectal Cancer Pathogenesis Using the NanoString GeoMx® Digital Spatial Profiler

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Spatial Analysis of Genomic Signatures on Colorectal Cancer Pathogenesis Using the NanoString GeoMx® Digital Spatial Profiler

Validation of recurrence prediction using circulating tumor DNA in patients with curatively treated early stage non-small cell lung cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Validation of recurrence prediction using circulating tumor DNA in patients with curatively treated early stage non-small cell lung cancer

Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer

Circulating tumor DNA (ctDNA) monitoring in breast cancer patients receiving neoadjuvant palbociclib and endocrine therapy. A secondary analysis of the NeoRHEA phase 2 study

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Circulating tumor DNA (ctDNA) monitoring in breast cancer patients receiving neoadjuvant palbociclib and endocrine therapy. A secondary analysis of the NeoRHEA phase 2 study

Optimization of an Integrated MultiOmyx-RNAscopehyperplexassay for co-detection and characterization of multiple protein and RNA biomarkers within the tumor microenvironment (TME)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Optimization of an Integrated MultiOmyx-RNAscopehyperplexassay for co-detection and characterization of multiple protein and RNA biomarkers within the tumor microenvironment (TME)

High-throughput analysis of immune biomarkers from brightfield whole tumor images using IndicaHALO®

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about High-throughput analysis of immune biomarkers from brightfield whole tumor images using IndicaHALO®

Spatial characterization of pro-inflammatory pathways in the pathogenesis of IBD associated colorectal cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Spatial characterization of pro-inflammatory pathways in the pathogenesis of IBD associated colorectal cancer

Molecular profiling of patients with colorectal cancer and their clinical implications

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Molecular profiling of patients with colorectal cancer and their clinical implications

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • …
  • Next page Next
  • Last page Last
Subscribe to